Emboliner® Total-Body Embolic Protection System
Embolic protection during Transcatheter Aortic Valve Replacement (TAVR)
Pivotal IDE TrialActive
Key Facts
Indication
Embolic protection during Transcatheter Aortic Valve Replacement (TAVR)
Phase
Pivotal IDE Trial
Status
Active
Company
About Emboline
Emboline is a clinical-stage medical device company targeting the significant unmet need for embolic protection during transcatheter cardiovascular procedures. Its flagship product, the Emboliner system, is engineered to provide comprehensive 'total-body' protection by capturing debris before it can travel to the brain, kidneys, and other organs. The company has completed enrollment in a pivotal 500-patient IDE trial comparing Emboliner to the market-leading Sentinel device, with data expected to support regulatory filings for FDA approval and CE Mark in Europe.
View full company profile